Asia-Pacific drug screening market is an upcoming market and expected to generate new opportunities for market players.
According to a new report published by Allied Market Research, titled, “the global drug screening market was valued at $5,214 million in 2016, and is projected to reach $9,447 million by 2026, growing at a CAGR of 8.7% from 2017 to 2026. North America held the largest market share with more than fifty percent share in 2016.” North America held five-ninths of the market share in global drug screening market, and is expected to continue this trend due its large amount of drug abuse and adoption of drug screening devices in the region. Drug screening is carried out to detect the presence of any illegal drug in the different biological samples such as blood or urine. Biological samples derived from the subject are tested under drug screening devices to diagnose the nature and amount of drug in the system. Drug screening manufacturers provide a wide range of high-tech equipment which is used by organizations and law enforcement agencies to check the presence of any illegal drug i...